OmniAb Inc

OmniAb insider trades reveal disciplined RSU vesting, not a market shift—insight into its antibody platform, reimbursement strategy, and investor entry points.

Insider trading at OmniAb shows disciplined liquidity and tax planning, yet confidence in its Fast‑Track antibody pipeline; investors weigh valuation discount against regulatory milestones.